1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global COPD and Asthma Diagnostic and Monitoring Devices Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for COPD and Asthma Diagnostic and Monitoring Devices by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for COPD and Asthma Diagnostic and Monitoring Devices by Country/Region, 2018, 2022 & 2029
2.2 COPD and Asthma Diagnostic and Monitoring Devices Segment by Type
2.2.1 Diagnostic Devices
2.2.2 Monitoring Devices
2.3 COPD and Asthma Diagnostic and Monitoring Devices Sales by Type
2.3.1 Global COPD and Asthma Diagnostic and Monitoring Devices Sales Market Share by Type (2018-2023)
2.3.2 Global COPD and Asthma Diagnostic and Monitoring Devices Revenue and Market Share by Type (2018-2023)
2.3.3 Global COPD and Asthma Diagnostic and Monitoring Devices Sale Price by Type (2018-2023)
2.4 COPD and Asthma Diagnostic and Monitoring Devices Segment by Application
2.4.1 Hospitals and Clinics
2.4.2 Home Care Settings
2.4.3 Others
2.5 COPD and Asthma Diagnostic and Monitoring Devices Sales by Application
2.5.1 Global COPD and Asthma Diagnostic and Monitoring Devices Sale Market Share by Application (2018-2023)
2.5.2 Global COPD and Asthma Diagnostic and Monitoring Devices Revenue and Market Share by Application (2018-2023)
2.5.3 Global COPD and Asthma Diagnostic and Monitoring Devices Sale Price by Application (2018-2023)
3 Global COPD and Asthma Diagnostic and Monitoring Devices by Company
3.1 Global COPD and Asthma Diagnostic and Monitoring Devices Breakdown Data by Company
3.1.1 Global COPD and Asthma Diagnostic and Monitoring Devices Annual Sales by Company (2018-2023)
3.1.2 Global COPD and Asthma Diagnostic and Monitoring Devices Sales Market Share by Company (2018-2023)
3.2 Global COPD and Asthma Diagnostic and Monitoring Devices Annual Revenue by Company (2018-2023)
3.2.1 Global COPD and Asthma Diagnostic and Monitoring Devices Revenue by Company (2018-2023)
3.2.2 Global COPD and Asthma Diagnostic and Monitoring Devices Revenue Market Share by Company (2018-2023)
3.3 Global COPD and Asthma Diagnostic and Monitoring Devices Sale Price by Company
3.4 Key Manufacturers COPD and Asthma Diagnostic and Monitoring Devices Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers COPD and Asthma Diagnostic and Monitoring Devices Product Location Distribution
3.4.2 Players COPD and Asthma Diagnostic and Monitoring Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for COPD and Asthma Diagnostic and Monitoring Devices by Geographic Region
4.1 World Historic COPD and Asthma Diagnostic and Monitoring Devices Market Size by Geographic Region (2018-2023)
4.1.1 Global COPD and Asthma Diagnostic and Monitoring Devices Annual Sales by Geographic Region (2018-2023)
4.1.2 Global COPD and Asthma Diagnostic and Monitoring Devices Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic COPD and Asthma Diagnostic and Monitoring Devices Market Size by Country/Region (2018-2023)
4.2.1 Global COPD and Asthma Diagnostic and Monitoring Devices Annual Sales by Country/Region (2018-2023)
4.2.2 Global COPD and Asthma Diagnostic and Monitoring Devices Annual Revenue by Country/Region (2018-2023)
4.3 Americas COPD and Asthma Diagnostic and Monitoring Devices Sales Growth
4.4 APAC COPD and Asthma Diagnostic and Monitoring Devices Sales Growth
4.5 Europe COPD and Asthma Diagnostic and Monitoring Devices Sales Growth
4.6 Middle East & Africa COPD and Asthma Diagnostic and Monitoring Devices Sales Growth
5 Americas
5.1 Americas COPD and Asthma Diagnostic and Monitoring Devices Sales by Country
5.1.1 Americas COPD and Asthma Diagnostic and Monitoring Devices Sales by Country (2018-2023)
5.1.2 Americas COPD and Asthma Diagnostic and Monitoring Devices Revenue by Country (2018-2023)
5.2 Americas COPD and Asthma Diagnostic and Monitoring Devices Sales by Type
5.3 Americas COPD and Asthma Diagnostic and Monitoring Devices Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC COPD and Asthma Diagnostic and Monitoring Devices Sales by Region
6.1.1 APAC COPD and Asthma Diagnostic and Monitoring Devices Sales by Region (2018-2023)
6.1.2 APAC COPD and Asthma Diagnostic and Monitoring Devices Revenue by Region (2018-2023)
6.2 APAC COPD and Asthma Diagnostic and Monitoring Devices Sales by Type
6.3 APAC COPD and Asthma Diagnostic and Monitoring Devices Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe COPD and Asthma Diagnostic and Monitoring Devices by Country
7.1.1 Europe COPD and Asthma Diagnostic and Monitoring Devices Sales by Country (2018-2023)
7.1.2 Europe COPD and Asthma Diagnostic and Monitoring Devices Revenue by Country (2018-2023)
7.2 Europe COPD and Asthma Diagnostic and Monitoring Devices Sales by Type
7.3 Europe COPD and Asthma Diagnostic and Monitoring Devices Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa COPD and Asthma Diagnostic and Monitoring Devices by Country
8.1.1 Middle East & Africa COPD and Asthma Diagnostic and Monitoring Devices Sales by Country (2018-2023)
8.1.2 Middle East & Africa COPD and Asthma Diagnostic and Monitoring Devices Revenue by Country (2018-2023)
8.2 Middle East & Africa COPD and Asthma Diagnostic and Monitoring Devices Sales by Type
8.3 Middle East & Africa COPD and Asthma Diagnostic and Monitoring Devices Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of COPD and Asthma Diagnostic and Monitoring Devices
10.3 Manufacturing Process Analysis of COPD and Asthma Diagnostic and Monitoring Devices
10.4 Industry Chain Structure of COPD and Asthma Diagnostic and Monitoring Devices
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 COPD and Asthma Diagnostic and Monitoring Devices Distributors
11.3 COPD and Asthma Diagnostic and Monitoring Devices Customer
12 World Forecast Review for COPD and Asthma Diagnostic and Monitoring Devices by Geographic Region
12.1 Global COPD and Asthma Diagnostic and Monitoring Devices Market Size Forecast by Region
12.1.1 Global COPD and Asthma Diagnostic and Monitoring Devices Forecast by Region (2024-2029)
12.1.2 Global COPD and Asthma Diagnostic and Monitoring Devices Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global COPD and Asthma Diagnostic and Monitoring Devices Forecast by Type
12.7 Global COPD and Asthma Diagnostic and Monitoring Devices Forecast by Application
13 Key Players Analysis
13.1 Becton Dickinson and Company
13.1.1 Becton Dickinson and Company Company Information
13.1.2 Becton Dickinson and Company COPD and Asthma Diagnostic and Monitoring Devices Product Portfolios and Specifications
13.1.3 Becton Dickinson and Company COPD and Asthma Diagnostic and Monitoring Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Becton Dickinson and Company Main Business Overview
13.1.5 Becton Dickinson and Company Latest Developments
13.2 Drägerwerk
13.2.1 Drägerwerk Company Information
13.2.2 Drägerwerk COPD and Asthma Diagnostic and Monitoring Devices Product Portfolios and Specifications
13.2.3 Drägerwerk COPD and Asthma Diagnostic and Monitoring Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Drägerwerk Main Business Overview
13.2.5 Drägerwerk Latest Developments
13.3 Getinge
13.3.1 Getinge Company Information
13.3.2 Getinge COPD and Asthma Diagnostic and Monitoring Devices Product Portfolios and Specifications
13.3.3 Getinge COPD and Asthma Diagnostic and Monitoring Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Getinge Main Business Overview
13.3.5 Getinge Latest Developments
13.4 Invacare Corporation
13.4.1 Invacare Corporation Company Information
13.4.2 Invacare Corporation COPD and Asthma Diagnostic and Monitoring Devices Product Portfolios and Specifications
13.4.3 Invacare Corporation COPD and Asthma Diagnostic and Monitoring Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Invacare Corporation Main Business Overview
13.4.5 Invacare Corporation Latest Developments
13.5 Masimo Corporation
13.5.1 Masimo Corporation Company Information
13.5.2 Masimo Corporation COPD and Asthma Diagnostic and Monitoring Devices Product Portfolios and Specifications
13.5.3 Masimo Corporation COPD and Asthma Diagnostic and Monitoring Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Masimo Corporation Main Business Overview
13.5.5 Masimo Corporation Latest Developments
13.6 Medtronic Plc
13.6.1 Medtronic Plc Company Information
13.6.2 Medtronic Plc COPD and Asthma Diagnostic and Monitoring Devices Product Portfolios and Specifications
13.6.3 Medtronic Plc COPD and Asthma Diagnostic and Monitoring Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Medtronic Plc Main Business Overview
13.6.5 Medtronic Plc Latest Developments
13.7 oninklijke Philips
13.7.1 oninklijke Philips Company Information
13.7.2 oninklijke Philips COPD and Asthma Diagnostic and Monitoring Devices Product Portfolios and Specifications
13.7.3 oninklijke Philips COPD and Asthma Diagnostic and Monitoring Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 oninklijke Philips Main Business Overview
13.7.5 oninklijke Philips Latest Developments
13.8 Nihon Kohden Corporation
13.8.1 Nihon Kohden Corporation Company Information
13.8.2 Nihon Kohden Corporation COPD and Asthma Diagnostic and Monitoring Devices Product Portfolios and Specifications
13.8.3 Nihon Kohden Corporation COPD and Asthma Diagnostic and Monitoring Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Nihon Kohden Corporation Main Business Overview
13.8.5 Nihon Kohden Corporation Latest Developments
13.9 Smiths Medical
13.9.1 Smiths Medical Company Information
13.9.2 Smiths Medical COPD and Asthma Diagnostic and Monitoring Devices Product Portfolios and Specifications
13.9.3 Smiths Medical COPD and Asthma Diagnostic and Monitoring Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Smiths Medical Main Business Overview
13.9.5 Smiths Medical Latest Developments
13.10 Vyaire Medical
13.10.1 Vyaire Medical Company Information
13.10.2 Vyaire Medical COPD and Asthma Diagnostic and Monitoring Devices Product Portfolios and Specifications
13.10.3 Vyaire Medical COPD and Asthma Diagnostic and Monitoring Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Vyaire Medical Main Business Overview
13.10.5 Vyaire Medical Latest Developments
14 Research Findings and Conclusion
※参考情報 慢性閉塞性肺疾患(COPD)および喘息は、世界中で多くの人々に影響を及ぼしている呼吸器疾患です。これらの病気は、呼吸機能の低下を伴う慢性的な状態であり、適切な診断と日常的な管理が必要です。このため、COPDおよび喘息の診断や監視を行うための各種装置が開発されています。これらの装置は、患者の健康状態を把握し、適切な治療を行うための重要なツールとなっています。 COPDおよび喘息の診断・監視装置の定義は、これらの病気の症状や発作を検出し、評価するための機器やシステムを指します。これらの装置は、患者の肺機能や呼吸状態をリアルタイムで監視し、必要に応じて医療従事者にデータを提供します。これにより、患者はより良い治療を受けることができ、病状の悪化を防ぐことが可能になります。 これらの診断・監視装置の特徴には、非侵襲的であること、持ち運びが容易であること、リアルタイムでのデータ取得が可能であることが挙げられます。また、多くの装置は患者が自宅で使用できるように設計されており、通院の負担を軽減し、より良い生活の質を提供します。さらに、データはスマートフォンやコンピュータと連携できるものが多く、患者自身や医療従事者が簡単にアクセスすることができるという利点もあります。 COPDおよび喘息を診断・監視するための装置には、さまざまな種類があります。たとえば、スパイロメーターは、肺活量や呼気流量を測定し、肺の機能を評価するための基本的な機器です。このデータは、喘息やCOPDの診断において重要な指標となります。また、ピークフローメーターは、患者が自宅で使用できる小型の装置で、呼気のピーク流量を測定することで、気道の状態を評価します。これは、喘息の発作を予測する上で重要な役割を果たします。 さらに、携帯型の酸素濃度計や肺機能測定装置も一般的に使用されています。これらの装置は、呼吸状態をより詳細に分析するための情報を提供し、医療従事者が適切な治療を行うための基礎データとなります。加えて、最近の技術革新により、スマートウォッチやフィットネストラッカーなども呼吸状態のモニタリングに利用されるようになっています。これらのデバイスは、心拍数や活動量とともに呼吸データを収集し、統合的な健康管理を支援します。 用途としては、COPDや喘息の早期発見、病態のモニタリング、治療効果の評価などが挙げられます。特に、入院や緊急時の対処が必要な状況を防ぐために、患者が日常生活の中で自らの病状を管理できるようにすることが重要です。さらに、医療機関でもこれらのデバイスを用いて、患者の状態を遠隔で監視することで、よりタイムリーな対応が可能となります。 関連技術としては、ビッグデータ解析や人工知能(AI)が影響しています。これらの技術は、収集したデータを分析し、患者ごとの最適な治療法を提案することを可能にします。また、IoT(モノのインターネット)技術を用いたデバイスは、インターネットを介してデータを即座に医療機関に送信することができ、リアルタイムでの健康管理を実現します。こうした技術の進化により、COPDや喘息の診断・監視方法はますます先進的かつ効率的になってきています。 最後に、COPDおよび喘息用の診断・監視装置は、患者にとって重要な自己管理のツールであり、医療従事者にとっても貴重なデータを提供します。これにより、患者の生活の質を向上させるとともに、病気の影響を最小限に抑えることが期待されています。新しい技術と共に進化し続けるこれらの装置は、未来の呼吸器疾患の管理においてますます重要な役割を果たすことでしょう。 |
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/